Evidence map›Paper›PMID 34359893›Full record

ReviewCells2021

Salivary Gland Tissue Engineering Approaches: State of the Art and Future Directions.

Lindsay R Piraino, Danielle S W Benoit, Lisa A DeLouise

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Bioengineering in salivary gland regeneration.Journal of biomedical science · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lindsay R PirainoDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14627, USA.ORCID 0000-0002-8503-9558
Danielle S W BenoitDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14627, USA.
Lisa A DeLouiseDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14627, USA.ORCID 0000-0001-9399-5112
University of Rochester Medical Center · USUniversity of Rochester · US

Funding

Engineered salivary gland tissue chips (Administrative Supplement)UH3DE027695 · NIDCR · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., DELOUISE, LISA A · 2019 to 2021
$3.0M
Engineered salivary gland tissue chipsUG3DE027695 · NIDCR · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., DELOUISE, LISA A · 2017 to 2018
$1.5M
Salivary gland tissue chip designed to screen preventative drugs for radiation-induced xerostomiaF31DE029658 · NIDCR · UNIVERSITY OF ROCHESTER · PI PIRAINO, LINDSAY ROSE · 2020 to 2022
$131k
NIDCR NIH HHS F31 DE029658NIDCR NIH HHS UG3 DE027695NIDCR NIH HHS UH3 DE027695
6 · The paper itself

Abstract

Salivary gland regeneration is important for developing treatments for radiation-induced xerostomia, Sjögren's syndrome, and other conditions that cause dry mouth. Culture conditions adopted from tissue engineering strategies have been used to recapitulate gland structure and function to study and regenerate the salivary glands. The purpose of this review is to highlight current trends in the field, with an emphasis on soluble factors that have been shown to improve secretory function in vitro. A PubMed search was conducted to identify articles published in the last 10 years and articles were evaluated to identify the most promising approaches and areas for further research. Results showed increasing use of extracellular matrix mimetics, such as Matrigel

Indexed as

AnimalsCell Culture TechniquesHumansSalivary GlandsTissue Engineeringcell culturemedia optimizationsalivary glandsoluble cuestissue engineering

Identifiers

PMID34359893
PMCPMC8303463
OpenAlexW3179164314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.